Skip to main content
Premium Trial:

Request an Annual Quote

Tripos, Université Laval, iPRG of the Association of Biomolecular Resource Facilities, Synamatix, Emory University

Premium
Tripos Commences Liquidating Distribution, Forms Liquidating Trust
 
Tripos has begun its initial liquidation dissolution pursuant to the plan of dissolution previously approved by the shareholders. Key steps in this phase of the liquidation include: trading of the common stock of Tripos, Inc., stopped at the close of business Nov. 8, 2007; trades initiated before the close of business Nov. 8 would be settled, but transfers of stock initiated after that time will not be processed; the previously announced initial liquidation distribution of Tripos, Inc., was effective as of market open today, Nov. 9, 2007.
 
Further, on Nov. 9, Mellon Investor Services LLC initiated the initial distribution of $0.47 per outstanding share of common stock, to Tripos, Inc., shareholders, with all remaining assets and liabilities following the initial distribution to shareholders.
 
The trustees will be Gary Meredith, Dr. John P. McAlister and The Bank of New York Mellon.
 
In addition, shareholders who hold positions in street name need take no further action and will receive the initial distribution through the Depository Trust Company (DTC) on or about Nov. 9, 2007.
 
Record holders of Tripos, Inc., stock will be paid the initial distribution against surrender of stock certificates and completed letters of transmittal, and the transfer of the balance of remaining Tripos, Inc., assets, with an estimated gross carrying value of approximately $4 million, primarily in cash, to the liquidating trust is in process.
 

 
Université Laval Adopts New Mitrionics Software Platform
 
Mitrionics, developer of the Mitrion Software Acceleration Platform, along with SGI announced this week that Université Laval of Canada, among other universities and companies, are using the companies’ combined, accelerated field programmable gate array technology platform and NCBI BLAST-n application.
 
The Mitrion-Accelerated BLAST application runs on a turnkey SGI RASC RC100 blade system equipped with FPGAs from Xilinx.
 
Leveraging the memory subsystem in SGI Altix servers and the Mitrion Virtual Processor, the NCBI BLAST application is designed to perform 20 to 60 times faster than the non-accelerated NCBI BLAST running on a quad-core Opteron processor, the companies said.
 
The performance increase range depends on the size of the queries, with very large queries having the highest performance, the companies added.
 
Nicolas Juge, research associate and director at Université Laval’s Center for Bioinformatics and Computational Biology, said that NCBI BLAST was chosen for its “architectural advantages and performance benefits over traditional systems and clusters.”
 

 
iPRG of the Assoc of Biomolecular Resource Facilities Studies Proteomics Labs
 
Given the guidelines of the Proteome Informatics Research Group, a new proposal is addressing the consistency of protein identification analysis via a standard methodology for reporting protein identification data.
 
The iPRG of the Association of Biomolecular Resource Facilities is inviting participation in a collaborative study focusing on evaluating the ability of proteomics laboratories to determine the identities of a complex mixture of proteins present in a single mass spectral dataset.
 
Chief goals of this study are to provide each participating laboratory an opportunity to evaluate its capabilities and approaches with regard to bioinformatifcs tools used to make and consolidate protein identifications derived from a common data set and a common reference database and report those identifications using common reporting criteria.
 
Laboratories requesting permission to participate will receive detailed instructions and passwords to access the mass spectral data, the reference database, and a template for reporting study results.
 
The study is open to ABRF members and non-members, though the number of participants may be limited and priority will be given to members.
 
Requests for participation must be submitted by e-mail to [email protected] before Nov. 19. Materials are expected to be distributed during the second week of November. Resulting data should be returned in mid-December. Results of the study will be presented at the ABRF annual conference in February 2008. 
 

 
Synamatix and Emory U Study Small RNA Based Brain Disease
 
Synamatix will collaborate on neurological disease analysis with the Emory University School of Medicine, it was announced this week.
 
Synamatix's role in this research will be to apply its SynaBASE and SXOligoSearch pattern-finding applications to process and analyze small RNAs generated from mouse brain cognitive disease studies.
 
Peng Jin is the project head from the dept. of Human Genetics at Emory University and said that Emory’s interests lie in conducting transcription profiling in mouse brains and identifying RNAs for future studies of brain disease, said Synamatix.

Filed under

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.